In its Decision, the Board instituted inter partes review of claims 1-39 of the ‘147 patent. The basis for the Board’s institution was the potential obviousness of these claims under 35 U.S.C. § 103 in view of the CRD Manual and the HP Journal. The Board gave consideration to the Declaration of Petitioners’ expert Dr. Andrew Hospodor in conducting its analysis.
Continue reading